Future Virology
Overview
Future Virology is a peer-reviewed journal that focuses on the latest advancements in virology research and its implications for future healthcare. It covers a wide range of topics including viral pathogenesis, diagnostics, therapeutics, and vaccine development, providing valuable insights into the evolving field of virology and its potential impact on public health.
Details
Details
Abbr.
Future Virol
Start
2006
End
Continuing
Frequency
18 issues a year, 2023-
p-ISSN
1746-0794
e-ISSN
1746-0808
Country
United Kingdom
Language
English
Specialty
Microbiology
Metrics
Metrics
h-index / Ranks: 7992
45
SJR / Ranks: 10903
366
CiteScore / Ranks: 7049
3.80
JIF / Ranks: 3327
3.1
Recent Articles
1.
Lansky A, Prejean J, Hall I
Future Virol
. 2025 Feb;
8(6):523-526.
PMID: 39958754
No abstract available.
2.
Gianella S, Haubrich R, Morris S
Future Virol
. 2024 Dec;
8(11):1037-1040.
PMID: 39640894
No abstract available.
3.
Subramanian S, Schnell G, di Iulio J, Gupta A, Shapiro A, Sarkis E, et al.
Future Virol
. 2023 Dec;
PMID: 38074312
Sotrovimab is an engineered human monoclonal antibody that binds a conserved region of the SARS-CoV-2 spike protein. The COMET-ICE phase III study evaluated sotrovimab for treatment of mild to moderate...
4.
Abdelrady Y, Ashraf N, Hamid A, Thabet H, Sayed A, Salem S, et al.
Future Virol
. 2023 Dec;
18(5):295-308.
PMID: 38052000
Aim: We aimed to investigate the potential inhibitory effects of diterpenes on SARS-CoV-2 main protease (Mpro). Materials & Methods: We performed a virtual screening of diterpenoids against Mpro using molecular...
5.
Tavakoli R, Rahimi P, Hamidi-Fard M, Eybpoosh S, Doroud D, Ahmadi I, et al.
Future Virol
. 2023 Dec;
18(9):563-574.
PMID: 38051999
Aim: The present study aimed to determine a correlation between differential expression levels and severe infections of COVID-19 between the Alpha, Delta and Omicron BA.5 variants. Materials & Methods: This...
6.
Liu J, Cang T, Jiang C, Li K, Liu S, Wang H, et al.
Future Virol
. 2023 Dec;
18(7):403-410.
PMID: 38051998
Aim: This study used CpG 684 as adjuvant of inactivated COVID-19 vaccine to detect a humoral and cellular immune response in mice. Materials & Methods: We used 10 and 20 ...
7.
Horga A, Kuritzkes D, Kowalczyk J, Pietropaolo K, Belanger B, Lin K, et al.
Future Virol
. 2023 Dec;
18(8):489-500.
PMID: 38051993
Background: Bemnifosbuvir, a novel, oral, nonmutagenic, nonteratogenic nucleotide analogue inhibits SARS-CoV-2 replication . Materials & Methods: Adults in hospital settings with moderate COVID-19 were randomized 1:1 bemnifosbuvir/placebo. Study amended to...
8.
Nguyen C, Luong B, Thi Tran T, Nguyen H, Tran L
Future Virol
. 2023 Dec;
18(8):501-516.
PMID: 38051989
Aim: To generate mRNAs encoding conserved regions within SARS-CoV-2 ORF1ab which can induce strong T-cell responses to overcome the immune invasion of newly emergent variants. Methods: We selected two conserved...
9.
Alanzi A, Parvez M, Al-Dosari M
Future Virol
. 2023 Dec;
18(7):421-438.
PMID: 38051986
Aim: Structure-based identification of natural compounds against SARS-CoV-2, Delta and Omicron target proteins. Materials & Methods: Several known antiviral natural compounds were subjected to molecular docking and MD simulation against...
10.
Rabelo V, da Silva V, Sanchez Nunez M, Dos Santos Correa Amorim L, Buarque C, Kuhn R, et al.
Future Virol
. 2023 Nov;
18(13):865-880.
PMID: 37974899
Aim: This work aimed to investigate the antiviral activity of two 1,4-disubstituted-1,2,3-triazole derivatives ( and ) against Chikungunya virus (CHIKV) replication. Materials & Methods: Cytotoxicity was analyzed using colorimetric assays...